Israel Englander’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-20,000
Closed -$320K 3805
2019
Q4
$320K Buy
+20,000
New +$305K ﹤0.01% 3635
2017
Q4
Sell
-100,000
Closed -$1.71M 3768
2017
Q3
$1.71M Buy
+100,000
New +$1.68M ﹤0.01% 2247

Other funds holding ANGO

Israel Englander's ANGO Position: Q2 2026 in Review

Israel Englander increased its AngioDynamics (ANGO) stake by 21% in Q2 2026, buying an estimated $1.58M and bringing the position to 783,125 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2260.

Israel Englander first reported a position in ANGO in Q3 2013 and has held it in 46 quarters since. The position peaked at $43.6M in Q2 2021. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Israel Englander held 783,125 shares of AngioDynamics worth $10.2M as of Q2 2026.
  • Israel Englander bought 138,448 AngioDynamics shares in Q2 2026, an estimated $1.58M.
  • AngioDynamics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2260 holding.
  • Israel Englander first reported a position in AngioDynamics in Q3 2013 and has held it in 46 quarters since.
  • Israel Englander's AngioDynamics position peaked at $43.6M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.